Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ClairYg vs Tégéline in maintenance treatment of CIDP
2012-001996-34Phase 3Completed
- Sponsor
- LFB Group
- Start
- Sep 2012
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of Human normal immunoglobulin G in chronic inflammatory demyelinating polyneuropathy (CIDP) (2 arms), sponsored by LFB Group. Started Sep 2012; status: completed.
02
Drugs
Human normal immunoglobulin G
03
Conditions
chronic inflammatory demyelinating polyneuropathy (CIDP)
Beyond the preview
Go deeper on 2012-001996-34.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-001996-34.